The present invention relates to heterobiaryl cyclohexyl tetraazabenzo[]azulenes of formula (I) wherein R R and R are as described herein. The compounds according to the invention act as V1a receptor modulators and in particular as V1a receptor antagonists their manufacture pharmaceutical compositions containing them and their use as medicaments. The active compounds of the present invention are useful as therapeutics acting peripherally and centrally in the conditions of dysmenorrhea male or female sexual dysfunction hypertension chronic heart failure inappropriate secretion of vasopressin liver cirrhosis nephrotic syndrome anxiety depressive disorders obsessive compulsive disorder autistic spectrum disorders schizophrenia and aggressive behavior.
